Cargando...
Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised mice
Acute myelogenous leukemia (AML) has an overall poor survival rate and shows considerable molecular heterogeneity in its etiology. In the WHO classification there are >50 cytogenetic subgroups of AML, many showing highly specific chromosome translocations that lead to constitutive activation of i...
Gardado en:
| Publicado en: | Int J Cancer |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5754922/ https://ncbi.nlm.nih.gov/pubmed/27005999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.30100 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|